Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Labs in the Netherlands are joining together to launch an AI model validation study for PD-L1 scoring with a goal of multi-source domain adaptation. Introduction  Programmed death-ligand 1 (PDL1) is a protein that, when attached to T...

. We hope to see you at our USCAP seminar and live Q&A! Whole Slide Imaging & Digital Pathology: Solutions for Clinical Practice Wednesday, March 17, 2021 12:45pm PST l 3:45pm EST Add to your itinerary SESSION DETAILS In this...

New Developments in Leukemia Apr 20, 2021 9 am PT / Noon ET Host: Derek Lyle, MD; Medical Director, NeoGenomics Speaker: Daniel A. Arber, MD; Chair of Pathology and Donald West and Mary Elizabeth King Professor of Pathology, The...

March 16, 2021 at 17:00 CET  Jacob Gildenblat, DeePathology's CTO, will present the new features of the DeePathology STUDIO including: Enhanced cell detection mode for quickly creating algorithms in complex scenarios Powerful...

NeoGenomics would like to invite you to our Molecular Tumor Boards. During each meeting, multidisciplinary teams will have a live discussion consulting on multiple cases with expert oncologists and discuss optimal treatment plans. Previous...

How Motic Uses Digital Pathology to Combat Cervical Cancer Cervical cancer is considered a leading cause of cancer-related deaths among women worldwide. Let that sink in — a cancer that’s largely preventable by the HPV vaccine and, at...